Drug Profile
High-dose grass pollen allergen - Allergopharma
Alternative Names: Allerslit forteLatest Information Update: 05 Jun 2015
Price :
$50
*
At a glance
- Originator Allergopharma
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 05 Jun 2015 No recent reports of development identified - Phase-III for Seasonal allergic rhinitis (In adults) in Germany (Sublingual)